Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 Cases (1990-2006)

Genevieve M. Hammond, Ira K. Gordon, Alain P Theon, Michael S Kent

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective - To determine progression-free and overall survival times of cats with squamous cell carcinoma (SCC) of the nasal planum following treatment with a single fraction of strontium Sr 90 (90Sr). Design - Retrospective case series. Animals - 49 cats with SCC of the nasal planum. Procedures - Information including FIV infection status, diagnosis of SCC vs SCC in situ (ie, evidence that the tumor did or did not penetrate the epidermal basement membrane, respectively), 90Sr dose and number of probe applications, treatment-related response and complications, and recurrence of SCC and new lesion development was obtained from medical records. The relationships of these variables with calculated progression-free and overall survival times were assessed. Results - Of 49 cats that underwent 90Sr plesiotherapy (median dose, 128 Gy), 48 (98%) had a response to treatment and 43 (88%) had a complete response. Median progression-free and overall survival times were 1,710 and 3,076 days, respectively. Treatment complications were infrequent (4 [8%] cats) and mild. Following treatment, the SCC recurrence rate was 20% (10/49 cats); 16 (33%) cats developed new lesions in other locations. Overall survival time was significantly longer for cats with a complete response to treatment than for those with a partial response. None of the other variables evaluated had a significant effect on progression-free or overall survival time. Conclusions and Clinical Relevance - Treatment of cats with SCC of the nasal planum with a single fraction of 90Sr appeared to be effective and well tolerated. Initial response to treatment was predictive of overall survival time.

Original languageEnglish (US)
Pages (from-to)736-741
Number of pages6
JournalJournal of the American Veterinary Medical Association
Volume231
Issue number5
DOIs
StatePublished - Sep 1 2007

Fingerprint

Strontium
Temazepam
strontium
squamous cell carcinoma
Nose
Squamous Cell Carcinoma
Cats
cats
Disease-Free Survival
lesions (animal)
Feline Immunodeficiency Virus
Recurrence
Carcinoma in Situ
basement membrane
dosage
Basement Membrane
probes (equipment)
Medical Records
neoplasms
Infection

ASJC Scopus subject areas

  • veterinary(all)

Cite this

@article{60b23d39087a40d1bbeec1ab291e3c48,
title = "Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 Cases (1990-2006)",
abstract = "Objective - To determine progression-free and overall survival times of cats with squamous cell carcinoma (SCC) of the nasal planum following treatment with a single fraction of strontium Sr 90 (90Sr). Design - Retrospective case series. Animals - 49 cats with SCC of the nasal planum. Procedures - Information including FIV infection status, diagnosis of SCC vs SCC in situ (ie, evidence that the tumor did or did not penetrate the epidermal basement membrane, respectively), 90Sr dose and number of probe applications, treatment-related response and complications, and recurrence of SCC and new lesion development was obtained from medical records. The relationships of these variables with calculated progression-free and overall survival times were assessed. Results - Of 49 cats that underwent 90Sr plesiotherapy (median dose, 128 Gy), 48 (98{\%}) had a response to treatment and 43 (88{\%}) had a complete response. Median progression-free and overall survival times were 1,710 and 3,076 days, respectively. Treatment complications were infrequent (4 [8{\%}] cats) and mild. Following treatment, the SCC recurrence rate was 20{\%} (10/49 cats); 16 (33{\%}) cats developed new lesions in other locations. Overall survival time was significantly longer for cats with a complete response to treatment than for those with a partial response. None of the other variables evaluated had a significant effect on progression-free or overall survival time. Conclusions and Clinical Relevance - Treatment of cats with SCC of the nasal planum with a single fraction of 90Sr appeared to be effective and well tolerated. Initial response to treatment was predictive of overall survival time.",
author = "Hammond, {Genevieve M.} and Gordon, {Ira K.} and Theon, {Alain P} and Kent, {Michael S}",
year = "2007",
month = "9",
day = "1",
doi = "10.2460/javma.231.5.736",
language = "English (US)",
volume = "231",
pages = "736--741",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "5",

}

TY - JOUR

T1 - Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats

T2 - 49 Cases (1990-2006)

AU - Hammond, Genevieve M.

AU - Gordon, Ira K.

AU - Theon, Alain P

AU - Kent, Michael S

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Objective - To determine progression-free and overall survival times of cats with squamous cell carcinoma (SCC) of the nasal planum following treatment with a single fraction of strontium Sr 90 (90Sr). Design - Retrospective case series. Animals - 49 cats with SCC of the nasal planum. Procedures - Information including FIV infection status, diagnosis of SCC vs SCC in situ (ie, evidence that the tumor did or did not penetrate the epidermal basement membrane, respectively), 90Sr dose and number of probe applications, treatment-related response and complications, and recurrence of SCC and new lesion development was obtained from medical records. The relationships of these variables with calculated progression-free and overall survival times were assessed. Results - Of 49 cats that underwent 90Sr plesiotherapy (median dose, 128 Gy), 48 (98%) had a response to treatment and 43 (88%) had a complete response. Median progression-free and overall survival times were 1,710 and 3,076 days, respectively. Treatment complications were infrequent (4 [8%] cats) and mild. Following treatment, the SCC recurrence rate was 20% (10/49 cats); 16 (33%) cats developed new lesions in other locations. Overall survival time was significantly longer for cats with a complete response to treatment than for those with a partial response. None of the other variables evaluated had a significant effect on progression-free or overall survival time. Conclusions and Clinical Relevance - Treatment of cats with SCC of the nasal planum with a single fraction of 90Sr appeared to be effective and well tolerated. Initial response to treatment was predictive of overall survival time.

AB - Objective - To determine progression-free and overall survival times of cats with squamous cell carcinoma (SCC) of the nasal planum following treatment with a single fraction of strontium Sr 90 (90Sr). Design - Retrospective case series. Animals - 49 cats with SCC of the nasal planum. Procedures - Information including FIV infection status, diagnosis of SCC vs SCC in situ (ie, evidence that the tumor did or did not penetrate the epidermal basement membrane, respectively), 90Sr dose and number of probe applications, treatment-related response and complications, and recurrence of SCC and new lesion development was obtained from medical records. The relationships of these variables with calculated progression-free and overall survival times were assessed. Results - Of 49 cats that underwent 90Sr plesiotherapy (median dose, 128 Gy), 48 (98%) had a response to treatment and 43 (88%) had a complete response. Median progression-free and overall survival times were 1,710 and 3,076 days, respectively. Treatment complications were infrequent (4 [8%] cats) and mild. Following treatment, the SCC recurrence rate was 20% (10/49 cats); 16 (33%) cats developed new lesions in other locations. Overall survival time was significantly longer for cats with a complete response to treatment than for those with a partial response. None of the other variables evaluated had a significant effect on progression-free or overall survival time. Conclusions and Clinical Relevance - Treatment of cats with SCC of the nasal planum with a single fraction of 90Sr appeared to be effective and well tolerated. Initial response to treatment was predictive of overall survival time.

UR - http://www.scopus.com/inward/record.url?scp=34548456759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548456759&partnerID=8YFLogxK

U2 - 10.2460/javma.231.5.736

DO - 10.2460/javma.231.5.736

M3 - Article

C2 - 17764434

AN - SCOPUS:34548456759

VL - 231

SP - 736

EP - 741

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 5

ER -